<DOC>
	<DOCNO>NCT02608996</DOCNO>
	<brief_summary>Hypertension remain global burden cardiovascular disease lead stroke , myocardial infarction , heart failure . Its myocardial complication result increased mechanical load heart . Under physiological condition increase myocardial load result myocardial stretch , atrial natriuretic peptide ( ANP ) B-type natriuretic peptide ( BNP ) synthesis secretion occur contribute maintenance optimal cardiorenal blood pressure homeostasis . However , study indicate subject cardiovascular disease biological structure hormone may alter , thus reduce favorable protective activity . New study indicate early moderate hypertension associate derangement natriuretic peptide system characterize lack activation biologically active ANP BNP , severe hypertension characterize Cardiac release alter molecular form ANP BNP reduce biological Properties and/or enhance degradation . The broad objective proposal advance biology therapeutic NPs special focus cardiac peptide BNP human hypertension . Our proposal base upon biological property BNP ( i.e . natriuretic , renin-angiotensin-aldosterone suppressing , vasodilating , anti-fibrotic , anti-hypertrophic positive lusitropic ) , mechanistic role human hypertension , thus potential innovative chronic protein therapeutic enhance treatment patient uncontrolled hypertension . Importantly , BNP endocrine hormone normally produce human heart , approve treatment acute heart failure USA .</brief_summary>
	<brief_title>Nesiritide Uncontrolled Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Office systolic blood pressure ( SBP ) and/or diastolic blood pressure ( DBP ) ≥ 150/90 mmHg despite treatment least one antihypertensive medication . Unchanged medication regimen last two week prior inclusion . For patient diabetes BP ≥ 150/85 mmHg sufficient . Average daytime SBP &gt; 135 DBP &gt; 85 mmHg 24h ambulatory BP measurement screening . Congestive Heart Failure ( New York Heart Association class ) Ejection Fraction ≤ 40 % Known , appropriately treat , secondary hypertension Myocardial infarction within 3 month screen Unstable angina within 14 day screen , evidence myocardial ischemia Pulmonary hypertension Aortic stenosis maximum jet velocity &gt; 2,5 m/s Other valvular stenosis , hypertrophic , restrictive obstructive cardiomyopathy , constrictive pericarditis biopsy proven active myocarditis Sustained Ventricular Tachycardia Ventricular Fibrillation within 14 day screen Sustained Atrial Fibrillation Second third degree atrioventricular block without permanent cardiac pacemaker Cerebrovascular event within 3 month screen , evidence significantly compromise cerebral perfusion Proteinuria define albumin : creatinine ratio &gt; 100 ( equivalent excretion &gt; 1 g/day ) Nephrotic syndrome Body Mass Index &gt; 35 Total bilirubin &gt; 25 µmol/L , aspartate aminotransferase alanine aminotransferase 1.5 time upper limit normal range Renal insufficiency assess estimate glomerular filtration rate ( GFR ) &lt; 30 ml/min Serum sodium ≤ 135 mmol/L ≥ 150 mmol/L Serum potassium ≤ 3.5 mmol/L ≥ 5.5 mmol/L Women take hormonal contraceptive hormone replacement therapy contain estrogen Pregnancy Patients prolong , i.e . 30 day , immunosuppressant therapy Patients know , active malignancy Patients orthostatic hypotension Participation trial investigational Product within previous three month Any contraindication list Investigator 's Brochure Investigational Medicinal Product Any reason , opinion investigator , patient participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>